Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats

BACKGROUND: There are no approved drug treatments for liver fibrosis and nonalcoholic steatohepatitis (NASH), an advanced stage of fibrosis which has rapidly become a major cause of cirrhosis. Therefore, development of anti-inflammatory and antifibrotic therapies is desired. Mesenchymal stem cell- (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohara, Masatsugu, Ohnishi, Shunsuke, Hosono, Hidetaka, Yamamoto, Koji, Yuyama, Kohei, Nakamura, Hideki, Fu, Qingjie, Maehara, Osamu, Suda, Goki, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323530/
https://www.ncbi.nlm.nih.gov/pubmed/30675167
http://dx.doi.org/10.1155/2018/3212643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323530/
https://www.ncbi.nlm.nih.gov/pubmed/30675167
http://dx.doi.org/10.1155/2018/3212643

Ejemplares similares